Podcasts about canopy growth corp

Sipping on the Green Wave: Exploring Cannabis Beverages with Paul Weaver of Boston Beer CompanyIn this engaging episode of "Thinking Outside the Bud," Bruce Eckfeldt leads a captivating conversation with Paul Weaver, Director, Head of Cannabis at the Boston Beer Company. The episode centers on the cannabis beverage industry, exploring regulatory changes, market intricacies, and challenges inherent in entering the cannabis sector. Weaver shares his professional journey from the beer industry to leading product innovation at Canopy Growth Corp, eventually spearheading a cannabis R&D department for the Boston Beer Company and successfully launching their cannabis-infused iced tea, Tea Pot.Weaver emphasizes the social acceptability and powerful branding impact of cannabis drinks, incorporating personal anecdotes, insights into industry evolution, and considerations of potential competition with alcohol. The conversation covers critical factors such as flavor and potency stability, addressing both challenges and opportunities in crafting appealing cannabis products. Delving into disparities in cannabis and alcohol consumption, the dialogue explores onset times, potency variations, and the importance of responsible use.The episode provides valuable insights into the cannabis beverage market, highlighting the rise of rare cannabinoids and the significance of low-dose products. Weaver and Eckfeldt unravel the intricacies of consumer education, particularly regarding onset times and moderation, drawing parallels between public consumption in the cannabis and alcohol industries. The discussion concludes with a focus on branding strategies, where Weaver emphasizes the necessity of exceptional products and discusses challenges stemming from cannabis marketing restrictions. He introduces a double-sale approach to foster brand loyalty by targeting both consumers and budtenders. In its entirety, the episode offers a thorough exploration of the dynamic landscape of the cannabis beverage market, providing considerations for navigating regulations and expanding into diverse markets.www.instagram.com/drinkteapot

A lot has happened since 2018, but if you think back to that time, you might remember that Canada's cannabis industry was booming.  There were multiple Canadian cannabis businesses that were valued at multiple billions of dollars. People were getting rich trading weed stocks and starting weed companies.  And this wasn't just money moving around, like with meme stocks during the pandemic. The largest companies, like Canopy, Aurora, and Aphria, were spending money to build massive facilities across Canada and hiring thousands of people.  Then it all came crashing down.  Last week, the Nasdaq stock exchange said it would delist Canopy Growth Corp because its stock, which once traded for around $60, has been below the Nasdaq's $1 threshold for too long.  So what happened? On today's episode, Jay Rosenthal joins me to explain what went wrong in the cannabis industry and talk about what's next for the sector both in Canada and the US.  Jay is the Director of Content at Dutchie, a leading tech partner for cannabis retailers around the world, and the co-founder of the Business of Cannabis. ----- Links: More episodes of Free Lunch by The Peak: https://readthepeak.com/shows/free-lunch Follow Taylor on Twitter: @taylorscollon Follow Sarah on Twitter: @sarahbartnicka Subscribe to The Peak's daily business newsletter: https://readthepeak.com/b/the-peak/subscribe

Are you following the podcast yet? If not, why not? Correct this at once, here -> Follow

Here's the latest from the "Cannabis Daily" podcast team!!Today's stories:Cannabis stocks in the US edged higher on Wednesday with Maryland and Missouri voting in favor of legalizing adult-use cannabis, reports Proactive Investors. The head of Canopy Growth Corp. has high hopes for the U.S. Senate and potential cannabis legislation after Tuesday's midterm elections, writes Market Screener. Time reports that cannabis is now attracting new investments from entrepreneurs ready to cash in on its popularity. But...Astrasana recently announced a new venture with Solumedics AG which will enable the company to import and sell medical cannabis in SwitzerlandTweet us and let us know your thoughts on today's episode, here.Email us about our stories, here.Missed the previous episode? You can catch up with it here. And here's some bonus content we released from the Business of Cannabis: New York Live event. About Cannabis Daily.Cannabis Daily is a cannabis news and interview program from Business of Cannabis. We highlight the companies, brands, people and trends driving the cannabis industry.Business of Cannabis is a cannabis industry platform marrying cannabis news, video and podcast content, newsletters and online and real-world cannabis events.Visit Business of Cannabis online:http://businessofcannabis.comTwitter: https://twitter.com/bofc_mediaLinkedIn: https://www.linkedin.com/company/businessofcannabisInstagram: https://instagram.com/businessofcannabisFacebook: https://www.facebook.com/bofcmediaSpotify: http://bofc.me/spotifyApple: http://bofc.me/applepodPodcasts Online: https://bofc.me/bofclive

Jon sits down for a cannaconvo with Nancy Whiteman, CEO of Wana Brands. Their conversation touches upon their recent partnership with Canopy, future plans for market expansion, and the future of the industry as a whole.Heralded as “The Queen of Legal Weed” by Inc. (May 2017) and “The Martha Stewart of Edibles” by Entrepreneur (Jan. 2019), Nancy Whiteman is co-founder and CEO of Wana Brands, a top international brand already available in more than 3,000 dispensaries across the United States and Canada. In October 2021, Canopy Growth Corp. announced it had purchased the right–upon federal permissibility of THC in the US–to acquire Wana Brands. With proceeds from the deal, Nancy established the Wana Brands Foundation, an organization working to enhance the world by supporting a wide variety of nonprofits in Wana's communities. Nancy leads Wana Brands' strategic vision and has been instrumental in the company's growth into new and emerging markets. She also directs the development of partnerships and licensing agreements domestically and internationally. Nancy has been recognized for numerous awards including Forbes' Most Influential People in Cannabis and High Times 100.

Jeff and Bruce dive deep into the world of cannabis investments with ETF Managers Group's cannabis research and banking expert Jason Wilson. Jason addresses how the industry will continue to shift as a result of changing regulations, what the rules are currently and how they're expected to change, and the difference between CBD and THC.  Guest Bio:Jason Wilson is cannabis research and banking expert  with ETF Managers Group. With over 20 years of experience in the asset management, finance and structured product space, Jason has a track record of bringing hard-to-access asset classes to market. Most recently, Jason was senior vice president at Infor Financial Inc., a leading boutique investment bank based in Toronto, Canada that has worked in connection with a number of companies in the legal cannabis industry, including acting as advisor to Canopy Growth Corp. in connection with entering into its strategic relationship with Constellation Brands.

On this week's episode, we welcome back Tej Virk, CEO of Akanda Corp - integrated medical cannabis company with operations in Africa and the UK.We examine the importance of ESG investments within the cannabis world, the opportunities they can bring, and the challenges that exist in this area.About Tej Virk​​Tej Virk is the CEO and Director of Akanda, an international medical cannabis company, cultivating ethically sourced cannabis in Lesotho. He started his career in investment banking, spending 15 years with BMO Capital Markets, with his final year focusing heavily on the cannabis industry. He transacted on over 100 IPOs and follow-on capital raises, including companies such as Canopy Growth Corp. and Tilray, before joining Canopy Growth Corp. in 2019, as Managing Director of Europe where he drove the multinational expansion of Canopy's European operations.  Virk then joined Khiron Life Sciences as President of Europe where he established the company's European medical and consumer packaged goods business from scratch.Virk has earned a reputation for industry leading innovation and successful execution in the global cannabis space, including overseeing multiple European pharmaceutical and consumer product launches, bleeding-edge regulatory work, accreditation of medical education platforms for health care providers, e-commerce rollouts, multiple sector M&As, establishing telemedicine partnerships, and setting up supply chains and distribution channels in every continent. Virk was a founding member and executive group stakeholder for Project Twenty21, the UK's largest medical cannabis study. The study published the first real-world data collected on medical cannabis in the UK, with findings indicating that legally prescribed cannabis provides clinically significant improvements in the quality of life of patients living with numerous medical conditions.Quotables‘I like to make a positive impact on society. That was one of my reasons for leaving the banking industry to to join the cannabis industry' 4:42ResourcesAkanda Corp's Website: https://akandacorp.com/Follow Akanda Corp on Instagram: https://www.instagram.com/akandacorp/?hl=enFollow Akanda Corp on Twitter:https://twitter.com/akandacorpJoin Tej on LinkedIn:https://www.linkedin.com/in/tej-virk-52403769/?originalSubdomain=ukFollow Tej on Instagram: https://www.instagram.com/tvlondon/?hl=enFollow Tej on Twitter: https://twitter.com/tejvirkceo?lang=en 

Hey Everyone! We're back with a new guest from a new industry in Episode 22! This time around we met with Amanda Daley, the Head of Medical at Canopy Growth, one of Canada's leading cannabis producers with a focus on research, product development and innovative production capabilities. Amanda's role includes all Canadian commercial medical activities for Spectrum Therapeutics, the medical division of Canopy Growth, including overseeing sales & marketing, and the creation and implementation of continuing medical education (CME) programs for healthcare professionals. With other previous experience in the pharmaceutical industry at Solvay and Pfizer, Amanda brought some great insights on how education can be used to drive uptake of new products, along with how she shook the stigma of jumping from pharmaceuticals to medical cannabis, where she sees the industry headed in the future, and other fun tales from Canopy Growth! Before we jump into the interview, Tyler brings forward some new research breakthroughs from the field of developing animal organs for use in human transplants. We certainly learned about some interesting new topics this time around and we can't wait for you to join us! --- Send in a voice message: https://anchor.fm/healthcarehubpodcast/message

Inovia raises a new $334 million fund. Canopy Growth Corp buys to option to buy Wana edibles. And LinkedIn is leaving China after a government crackdown on the platform. Celebrating something? Let us know for a shoutout here: https://thepeak.typeform.com/to/GuHjLDoa The Peak Daily is produced by 306 Media Productions. Hosted by Brett Chang and Jay Rosenthal.

I looked at the Federal Reserve statement that affected market indices. I also explored the marijuana industry's outlook in Canada and the United States, including Tilray's (#TLRY stock) earnings report and Canopy Growth Corp's (#CGC stock) status. Let's get to it!  

How to Launch a Great Cannabis Cultivation Business in Record TimeThe "Three G's" necessary for a cannabis cultivation facility to be successful are Genetics, Growers and Greenhouse.   Ryan Douglas from Ryan Douglas Cultivation  joins Larry and Jim  to share some of the lessons he's learned in his 20 plus years as a master grower for some of the largest cannabis companies in the world including Canopy Growth Corp.Produced By MJBullsDeadhead CyclistsFrom Seed to Success: How to Launch a Great Cannabis Cultivation Business in Record Time

Comparing the bought financing deals of MMED that are happening currently to the past deals done by Canopy Growth Corp when they were entering their insane rally in 2018 & 2019. Bruce Linton is the board chairman of MMED, and has his finger prints all over the company. Especially in their dealing with the capital markets, where his skills lie. He was also the co-CEO of Canopy Growth Corp when they ran to their highs from late 2019 until the decent in mid 2019. MMED is raising capital in a very similar way to Canopy Growth Corp, in an emerging industry as was Canopy in the weed sector and has a familiar face in its executive lounge with Bruce Linton. Comparing the two could be valuable towards gaining insights on MMED's run to recent highs, and the potential it has for the future.

There are many disciplines of the Cannabis industry that requires much education to really be considered a master and we would consider growing to be one of those disciplines. When we think about growing Cannabis, to some, it could seem like you plant seeds, and eventually, you will grow some flower. However, most of us know this is knot the case. When our friend, Tess Woods, from Tess Woods PR, called and asked if we would be interested in meeting a Master Grower, of course, we jumped at the opportunity. We are super excited for this episode where we get to learn from the Master Grower of the flagship subsidiary of Canopy Growth Corp, Tweed Inc. Ryan Douglas, has spent much of his adult life studying plants and building businesses and you do knot want to miss our chat! Ryan published a book titled, From Seed to Success to help us budding cannapreneurs make sense of growing operations and also break things down in a very digestible way. In this book, Ryan provides many amazing resources for prospective growers and entrepreneurs looking for help building their Infrastructure and developing the overall strategy. Join our Chat and to purchase Ryan's book please follow the link directly below! Buy Now: From Seed to Success by Ryan DouglasGuest: Ryan Douglas From Seed to Success by Ryan Douglashttps://douglascultivation.com/Host: Ry Russell WeedBudzRadio.comKnotPlastic.comSupport the show (https://www.paypal.com/paypalme/ryzabove)

The founder of the worlds largest cannabis company.As the founder a Canopy Growth Corp, Bruce Linton has experienced all aspects of running a cannabis business.  He joins Osiris an Nina to share his opinions on the responsibilities that cannabis companies should assume, he also share some cannabis economic predictions.Produced By MJBulls

The founder of the worlds largest cannabis company.As the founder a Canopy Growth Corp, Bruce Linton has experienced all aspects of running a cannabis business. He joins Osiris an Nina to share his opinions on the responsibilities that cannabis companies should assume, he also share some cannabis economic predictions.Produced By PodConX

Find out which Kardashian came out of the green closet, Martha Stewart joins with Canopy Growth Corp for CBD gummies. 6 states are ready to vote green and Marc gives us another crazy “When Cannabis Goes Bad” Story that will have you scratching your head. Search for legal license search.cannabis.ca.gov Learn more about your ad-choices at https://news.iheart.com/podcast-advertisers

There are 120+ known cannabinoids, and at least that many terpenes in the cannabis plant, each with its own chemical properties and effects. Hunter Land's job at Canopy Growth is to explore the interplay of those elements, and the vast potential in this plant. In this episode we discuss:Hunter's background with Dr. Ethan Russo, and involvement in the development of Epidiolex.The process for accessing the safety of cannabis-derived medicine, and what you can do to protect yourself when shopping for cannabis or CBD.Proper dosing of cannabinoids, and why it depends for each person.Why sublingual absorption might not be superior.Why isolates have a place in cannabis medicine.What Hunter calls the 'non-tourage effect'And more... listen and learn! 

In this episode, Len is joined by Mark Yegge. Mark is a Hedge Fund Manager and Founder of hackingmoney.com Len and Mark discuss investing in cannabis stocks, the roller coaster ride of the past few years and how some cannabis stocks are starting to 'pop' again during the pandemic..   In this episode What the charts can tell us Canopy Growth Corp. Is this stock going to bounce back? Buying at the right time Aurora Cannabis Innovative Industrial Properties Inc. Cronos Group Inc. Tilray Inc. What the market is doing now  

Craft Brew News 4/24/20Germany Cancels 2020 OktoberfestGerman officials today cancelled the country’s famed Oktoberfest celebration due to concerns about the COVID-19 pandemic.Bavarian Minister President Markus Söder said during a press conference. “It hurts. It’s such a pity,” “We have agreed that the risk is simply too high.”The festival, originally slated for September 19 through October 4, usually draws 6 million people to Munich. Chancellor Angela Merkel announced that all large events be cancelled through August 31; however, officials said Oktoberfest, or the Wiesn in local parlance, is too large of an undertaking to adjust or postpone.Event manager Clemens Baumgärtner said. “The Wiesn is a total work of art that you either do completely or not at all, and this work of art cannot be moved backwards or made in a smaller form,” Oktoberfest, which dates back to 1810, generates more than 1 billion euros for the city of Munich and draws 2 million travelers to the city from other countries, according to Reuters.Molson Coors Extends HEXO CBD Beverage Partnership to USMolson Coors Beverage Company is deepening its relationship with Quebec-based cannabis company HEXO, today announcing the launch of a new joint venture to produce non-alcoholic CBD-infused beverages in Colorado.The new venture, Truss CBD USA, will be majority owned by Molson Coors and operate as an independent company with its own board of directors, management and resources. All products will be produced in Colorado and distributed exclusively for sale within the state.Molson Coors isn’t the only major beer company exploring the potential for cannabis beverages in Canada, which approved legal sales in December 2019. Anheuser-Busch InBev and Toronto-based cannabis brand Tilray launched a joint venture to research both THC- and CBD-infused beverages in December 2018, with each side committing $50 million to the project. Constellation Brands, the world’s largest spirits company, also has a minority ownership in Canopy Growth Corp.According to cannabis market research firm Brightfield Group, the U.S. CBD beverage market was worth $143.1 million in 2019. Colorado ranks 10th in the country in terms of CBD beverage consumers by state, with that group representing 2.9% of U.S. users.Minnesota Allows Restaurants to Sell Beer and Wine To GoMinnesota Gov. Tim Walz signed legislation last week that permits the sale of beer and wine to-go from restaurants during the COVID-19 pandemic, according to the Associated Press.Walz said. “This is a small but important step to provide relief for the local restaurants that are struggling to keep their lights on during this pandemic.Restaurants and bars are now allowed to sell a bottle of wine or six-pack of beer with food orders.Atlanta-Based Monday Night Brewing Begins Rehiring Furloughed StaffAtlanta’s Monday Night Brewing shared last week that it had begun rehiring some of its furloughed employees.The company wrote on Instagram. “Because of your willingness to purchase directly from our small brewery and generous contributions, we will actually be able to bring some of our furloughed staff back onto payrollFour furloughed employees were brought back and other employees whose hours were cut have received additional work. Monday Night will continue donating 25% of to-go sales and 100% of donations to its staff fund.The company wrote. “Your willingness to step up to the plate for the survival of our brewery and our team has been an incredibly life-giving and humbling experience for us,” Craft Beer Storm Website: www.craftbeerstorm.com*** A Top 20 Podcast in Food on iTunes ***Subscribe to Craft Beer Storm Podcast iTunes: https://itunes.apple.com/us/podcast/craft-beer-storm/id1438117278?mt=2Michael Beara is the Host of Craft Beer Storm and Founder/Brewer at Beara Brewing Co. in Portsmouth, NH*** Interested in starting your own brewery? Our Portsmouth, NH TURNKEY facility is for sale! Follow link for more info:https://www.neren.com/Listing/2800-Lafayette-Rd-12A/5cdda2dabf34cb9150a7faebIf your Company, Hotel or Restaurant wants to book a CraftBeer Weekend or Craft Beer Evening for your guests or employees send an email to Michael@craftbeerstorm.com Michael PotortiFounder/BrewerHost of "Craft Beer Storm" Podcastmichael@craftbeerstorm.comLinked In: https://www.linkedin.com/in/craft-beer-storm-podcast-30776075/**LISTEN to our Craft Beer Storm Podcast and share with a friend**Craft Beer Storm Podcast iTunes: https://podcasts.apple.com/us/podcast/craft-beer-storm/id1438117278Craft Beer Storm You Tube: https://www.youtube.com/channel/UCp3PVuCGmywNWlGFh0N0ukg?view_as=subscriberCraft Beer Storm Podcast Stitcher: https://www.stitcher.com/podcast/podcast-center-la-2/craft-beer-stormCraft Beer Storm Linked In: https://www.linkedin.com/in/craft-beer-storm-podcast-30776075/Craft Beer Storm Facebook: https://www.facebook.com/craftbeerstorm/Craft Beer Storm Instagram: https://www.instagram.com/craftbeerstorm/

We answer questions posed from our website and subreddit on the cannabis industry. At the end we present an illustrative model of Canopy Growth Corp's sales compared to SG&A.

Cannabis stocks rallied for a second day last Wednesday, buoyed by a historic congressional committee passage of a bill that aims to lift the federal ban on weed, as well as strong gains for Curaleaf after it posted a narrower-than-expected third-quarter loss.  Curaleaf’s U.S.-listed shares CURLF, +15.23% CURA, +15.07% were last up 15%, as investors shrugged off its revenue miss. The Massachusetts-based company posted a loss of $6.8 million, or a penny a share, versus losses of $33.7 million, or 9 cents a share in the year-ago period. Revenue rose to $61.8 million from $21.4 million. Analysts polled by FactSet had expected losses of 2 cents a share on revenue of $63.6 million.  GMP analyst Robert Fagan, who rates the stock a buy, said the numbers were “largely in line with our relatively high expectations.” The revenue number was below his estimate of $67 million.  He highlighted positives, including good cost control, a sequential rise in sales and that vaping fears had only a mue effect on Select’s sales in the quarter. The company acquired the Select brand in May for CS1.27 billion ($954.7 million).  Read now: As pot stocks sink, these two guys just raised $120 million to buy Don’t miss: All the excuses cannabis companies are making for an ugly crop of earnings MKM analyst Bill Kirk raised his fair-value estimate on the stock to C$8 from C$6 but stuck with his neutral rating on the stock.  “Admittedly, after weak earnings reports for most of the sector, it feels nice to use positive numbers when talking about Curaleaf’s profitability,” the analyst wrote in a note. “However, we still can’t quite get there on valuation.” Sentiment on Wednesday was boosted after the House Judiciary Committee voted in favor of the Marijuana Opportunity Reinvestment and Expungement (MORE) Act, which looks to remove the federal ban on cannabis and expunge past convictions.  Read: Aurora Cannabis stock suffers worst day in more than five years, analyst says ‘it would be fair for investors not to believe them’ The bill, which is being introduced by Committee Chairman Jerrold Nadler, a New York Democrat, passed Wednesday by a 24-10 vote in favor. “The Senate will take its own time, but then the Senate always does,” Nadler said at a press conference on Tuesday to introduce the bill. He also aimed to sound upbeat ahead of Wednesday’s markup session for the bill: “The energy and the political pressure from the various states is growing rapidly. The Senate is subject to that, too. We’ll accomplish this.” Also read: House panel passes bill that aims to legalize marijuana, but top Democrat concedes ‘Senate will take its own time.’ In company news, Harvest Health & Recreation Inc. HRVSF, +8.07% HARV, +6.64% became the latest cannabis company to scale back a previously agreed deal, its plan to buy cannabis licenses in Pennsylvania, Delaware, New Jersey and Maryland from CannaPharmacy Inc. in a deal originally priced at $88 million in cash.  See now: Canada tells cannabis companies to improve disclosures of cross-holdings Instead, the companies have agreed that Harvest Health will acquire Franklin Labs LLC, a unit of CannaPharmacy, for $26 million that will be split between $15 million in cash and an $11 million promissory note. Harvest Chief Executive Jason Vedadi said the new terms will help the company advance its revenue and profitability goals.  Cannabis stocks are still going through a period of retrenchment after a deep slump in stock prices. Many companies are revising deal terms, cutting costs and considering asset sales as the legal market is developing more slowly than expected and companies continue to post losses. Harvest made the announcement as it posted a third-quarter loss of $39.1 million, or 14 cents a share, wider than the $453,000 loss posted in the year-earlier period. The company did not offer a per-share loss number for the year-earlier. Revenue rose to $33.2 million from $11.2 million. There are too few FactSet estimates to offer a reliable consensus. In a similar move, Neptune Wellness Solutions Inc. NEPT, +1.11% NEPT, +3.30%said Wednesday it has reached a mutual agreement with Canopy Growth Corp.CGC, +13.21% WEED, +15.66% to amend and restate their cannabis-processing agreement. The parties have agreed to an amended schedule of processing volumes committed to Neptune by Canopy and to the removal of certain preferential rights granted Canopy related to Neptune’s capacity and pricing.  “Effective June 30, 2020, volume and pricing will be negotiated between the two parties based on market conditions,” Neptune said in a statement. The 3-year term of the deal remains intact. Neptune’s U.S.-listed shares were down 3.7%, while Canopy was up about 12%.

Cannabis stocks rallied for a second day last Wednesday, buoyed by a historic congressional committee passage of a bill that aims to lift the federal ban on weed, as well as strong gains for Curaleaf after it posted a narrower-than-expected third-quarter loss.  Curaleaf’s U.S.-listed shares CURLF, +15.23% CURA, +15.07% were last up 15%, as investors shrugged off its revenue miss. The Massachusetts-based company posted a loss of $6.8 million, or a penny a share, versus losses of $33.7 million, or 9 cents a share in the year-ago period. Revenue rose to $61.8 million from $21.4 million. Analysts polled by FactSet had expected losses of 2 cents a share on revenue of $63.6 million.  GMP analyst Robert Fagan, who rates the stock a buy, said the numbers were “largely in line with our relatively high expectations.” The revenue number was below his estimate of $67 million.  He highlighted positives, including good cost control, a sequential rise in sales and that vaping fears had only a mue effect on Select’s sales in the quarter. The company acquired the Select brand in May for CS1.27 billion ($954.7 million).  Read now: As pot stocks sink, these two guys just raised $120 million to buy Don’t miss: All the excuses cannabis companies are making for an ugly crop of earnings MKM analyst Bill Kirk raised his fair-value estimate on the stock to C$8 from C$6 but stuck with his neutral rating on the stock.  “Admittedly, after weak earnings reports for most of the sector, it feels nice to use positive numbers when talking about Curaleaf’s profitability,” the analyst wrote in a note. “However, we still can’t quite get there on valuation.” Sentiment on Wednesday was boosted after the House Judiciary Committee voted in favor of the Marijuana Opportunity Reinvestment and Expungement (MORE) Act, which looks to remove the federal ban on cannabis and expunge past convictions.  Read: Aurora Cannabis stock suffers worst day in more than five years, analyst says ‘it would be fair for investors not to believe them’ The bill, which is being introduced by Committee Chairman Jerrold Nadler, a New York Democrat, passed Wednesday by a 24-10 vote in favor. “The Senate will take its own time, but then the Senate always does,” Nadler said at a press conference on Tuesday to introduce the bill. He also aimed to sound upbeat ahead of Wednesday’s markup session for the bill: “The energy and the political pressure from the various states is growing rapidly. The Senate is subject to that, too. We’ll accomplish this.” Also read: House panel passes bill that aims to legalize marijuana, but top Democrat concedes ‘Senate will take its own time.’ In company news, Harvest Health & Recreation Inc. HRVSF, +8.07% HARV, +6.64% became the latest cannabis company to scale back a previously agreed deal, its plan to buy cannabis licenses in Pennsylvania, Delaware, New Jersey and Maryland from CannaPharmacy Inc. in a deal originally priced at $88 million in cash.  See now: Canada tells cannabis companies to improve disclosures of cross-holdings Instead, the companies have agreed that Harvest Health will acquire Franklin Labs LLC, a unit of CannaPharmacy, for $26 million that will be split between $15 million in cash and an $11 million promissory note. Harvest Chief Executive Jason Vedadi said the new terms will help the company advance its revenue and profitability goals.  Cannabis stocks are still going through a period of retrenchment after a deep slump in stock prices. Many companies are revising deal terms, cutting costs and considering asset sales as the legal market is developing more slowly than expected and companies continue to post losses. Harvest made the announcement as it posted a third-quarter loss of $39.1 million, or 14 cents a share, wider than the $453,000 loss posted in the year-earlier period. The company did not offer a per-share loss number for the year-earlier. Revenue rose to $33.2 million from $11.2 million. There are too few FactSet estimates to offer a reliable consensus. In a similar move, Neptune Wellness Solutions Inc. NEPT, +1.11% NEPT, +3.30%said Wednesday it has reached a mutual agreement with Canopy Growth Corp.CGC, +13.21% WEED, +15.66% to amend and restate their cannabis-processing agreement. The parties have agreed to an amended schedule of processing volumes committed to Neptune by Canopy and to the removal of certain preferential rights granted Canopy related to Neptune’s capacity and pricing.  “Effective June 30, 2020, volume and pricing will be negotiated between the two parties based on market conditions,” Neptune said in a statement. The 3-year term of the deal remains intact. Neptune’s U.S.-listed shares were down 3.7%, while Canopy was up about 12%.

Bruce Linton is an entrepreneur who has been at the head of 16 different companies and presently occupies the position of Executive Chairman at Vireo Health International, Inc, Co-Chairman of Martello Technologies Group, Inc., and co-founder of online rental marketplace Ruckify. During this candid interview, Bruce talks about his successes and his sales failures, helping us appreciate the Growth Mindset, Storytelling and the true meaning of Entrepreneurship. He also talks about how and where he has managed to find extraordinary opportunities and what to look for.  If you want your sales and business to grow, take 20 minutes to learn from this incredibly successful business leader.    WHAT YOU WILL LEARN IN THIS EPISODE: Why Relationship Selling is oversold   How Bruce picks his ventures   Why salespeople should never mention their competition The Value of the public policy changes How to pitch investors using Storytelling techniques   SHOW NOTES [00:21] Intro [01:45] Welcome  [02:11] Business stories that inspire Bruce [03:10] Early years: Carlton University Student Association [03:18] Canopy Growth Corporation [03:34] How he became a serial entrepreneur [04:46] Get fired for your own ideas   [06:00] You are selling all the time [06:52] Common Mistakes salespeople make [07:00] Why Relationship selling is oversold [08:36] Do's and Dont's of sales pitching [09:10] Why you should never slam your competition [10:09] How Bruce picks industries to invest [11:14] The role of Public policy changes [12:45] Stories that excite Bruce's investors [13:09] Advice for using storytelling techniques [14:38] Challenges facing today’s sales leaders [15:50] The Art of Storytelling [17:28] Contact info  

In this episode, Mubarak Shah shares the A to Z on cannabis stocks -- the available cannabis stocks, what the industry is right now, and how you can get involved. For more in-depth information on CBD, check out the InPennyStock VIP on https://inpennystock.com/packages TIME CODES [00:19] Despite shady beginnings, cannabis is being legalized in different stages across the United States. So public companies are getting involved in the stock market. [01:16] Looking at publicly-traded cannabis stocks using Barchart. [02:25] These are a few of the different sectors of cannabis companies -- growers like Canopy Growth Corp, ancillary biotech companies like Gw Pharma ADR, companies that make ancillary products. [03:06] Cannabis is still federally illegal, but the cannabis stocks are fine to trade because they trade on a different market. A lot of them are on the OTCMKTS [04:16] There is a lot of volatility in the cannabis sector, but that doesn't mean that now is the right time to trade cannabis stocks. [05:16] To dive deeper into understanding the cannabis industry, check out New Cannabis Ventures at https://newcannabisventures.com. It is an app I use to keep up with ongoings in the cannabis industry. [06:06] There are two different chemical compounds in cannabis or marijuana -- THC, the psychoactive part of cannabis, and CBD (cannabidiol) [08:25] How the current vaping epidemic is affecting even top cannabis companies such as Altria Group (MO) [10:08] Summary: The growth is happening because of the legalization, and currently everything is going down. [10:28] Barchart.com is a great news aggregator to be able to keep up to date with certain sectors. Hope you enjoy! If you have any other questions related to trading, please feel free to reach out to us at admin@inpennystock.com or visit us at inpennystock.com Finally, it would be incredibly gracious of you to just take a quick minute and leave me a review/rating to let me know how I'm doing and how I can improve these episodes more for your benefit! Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode, Mubarak Shah shares the A to Z on cannabis stocks -- the available cannabis stocks, what the industry is right now, and how you can get involved. For more in-depth information on CBD, check out the InPennyStock VIP on https://inpennystock.com/packages TIME CODES [00:19] Despite shady beginnings, cannabis is being legalized in different stages across the United States. So public companies are getting involved in the stock market. [01:16] Looking at publicly-traded cannabis stocks using Barchart. [02:25] These are a few of the different sectors of cannabis companies -- growers like Canopy Growth Corp, ancillary biotech companies like Gw Pharma ADR, companies that make ancillary products. [03:06] Cannabis is still federally illegal, but the cannabis stocks are fine to trade because they trade on a different market. A lot of them are on the OTCMKTS [04:16] There is a lot of volatility in the cannabis sector, but that doesn't mean that now is the right time to trade cannabis stocks. [05:16] To dive deeper into understanding the cannabis industry, check out New Cannabis Ventures at https://newcannabisventures.com. It is an app I use to keep up with ongoings in the cannabis industry. [06:06] There are two different chemical compounds in cannabis or marijuana -- THC, the psychoactive part of cannabis, and CBD (cannabidiol) [08:25] How the current vaping epidemic is affecting even top cannabis companies such as Altria Group (MO) [10:08] Summary: The growth is happening because of the legalization, and currently everything is going down. [10:28] Barchart.com is a great news aggregator to be able to keep up to date with certain sectors. Hope you enjoy! If you have any other questions related to trading, please feel free to reach out to us at admin@inpennystock.com or visit us at inpennystock.com Finally, it would be incredibly gracious of you to just take a quick minute and leave me a review/rating to let me know how I'm doing and how I can improve these episodes more for your benefit! Learn more about your ad choices. Visit megaphone.fm/adchoices

Are you secretly googling questions about cannabis? How to Do the Pot is a modern woman's guide to legal cannabis. Each episode addresses topics unique to women's well-being with input from a diverse range of voices - to inform, educate and demystify cannabis. In 2016, host April Pride founded Van der Pop, a female-focused cannabis brand. By 2018, it was acquired by Canopy Growth Corp., the world's largest cannabis company. She knows how to do the pot and wants to share what she’s learned with women everywhere. From the minds behind Dirty John, Call Your Girlfriend, and Planet Money. Sign up for the How to Do the Pot newsletter here --- Send in a voice message: https://anchor.fm/olm/message

When Bruce Linton was unceremoniously canned from his position as co-CEO of Canopy Growth Corp earlier this year, the cannabis world was stunned. Linton is one of the stars of the business. We caught up with him at the NCIA conference in San Jose to talk about his future and where he sees the opportunities in the business.

When Bruce Linton was unceremoniously canned from his position as co-CEO of Canopy Growth Corp earlier this year, the cannabis world was stunned. Linton is one of the stars of the business. We caught up with him at the NCIA conference in San Jose to talk about his future and where he sees the opportunities in the business.

Pyramid schemes are still alive and well. OG.Kennedy gives a deep dive on AMWAY. These are the main marijuana news on this episode: There seems to be a clear shortage of high-quality CBD hemp seed, with most reputable vendors out of stock. Constellation Brands Inc. disclosed that its share of Canopy Growth Corp. quarterly losses amounted to $106 million. Google Is Testing the Waters for CBD Ads With Trial Program, France eyeing a legalization bill that give gov a monopoly on marijuana sales The House of Representatives also approved an amendment from Rep. Alexandria Ocasio-Cortez (D-NY) stripping $5 million from the Drug Enforcement Administration and redirecting it to opioid treatment as well as a separate measure directing the Food and Drug Administration to formulate CBD regulations. US House protects state-legal cannabis programs

Bob Mintz, former federal prosecutor and Partner at McCarter & English, with legal analysis of the Mueller report. Karen Ubelhart, Senior Industrials analyst for Bloomberg Intelligence, on Honeywell earnings and outlook for industrials. Jacob Frenkel, former federal prosecutor with an Independent Counsel, now partner at Dickinson Wright, discusses Attorney General Barr's handling of the Mueller report. Kristine Owram, on discuss Canopy Growth Corp. buying Acreage Holdings Inc. for about $3.4 billion, in what would be the first major cross-border cannabis merger. Hosted by Lisa Abramowicz and Paul Sweeney. 

This week we announce our name change, and dive right in with the Amazon HQ2 (2:00). We also break down the Berkshire Hathaway buys and sells (5:00). We have our Watch the Throne with Coca-Cola (8:00). Break down Twilio Earnings (10:00), and have a Wake and Bake with Canopy Growth Corp. (12:00). Then it's time for the crazy Crypto news (13:00). We talk who's in hot water this week (15:00) and we break down our Million Dollar Mock Portfolio performance (20:00). --- This episode is sponsored by · Anchor: The easiest way to make a podcast. https://anchor.fm/app Support this podcast: https://anchor.fm/chit-chat-money/support

Why Weed Stocks are Increasing The largest pot company by market value, Canopy Growth Corp., reported a 282% increase in quarterly revenue as marijuana became legal in Canada, but earnings were slammed by paper losses, according to a securities filing late Thursday evening. Canopy CGC, +3.12% WEED, +2.50% shares rose as high as 7.9% before levelling out to roughly a 3% gain in early-morning trading Friday. Canopy shares have more than doubled in the past year, as the S&P 500 index SPX, +1.09% has gained 2%. Canopy’s fiscal third-quarter results were being closely watched as investors sought a further look at the state of recreational cannabis sales in Canada, after rival Aurora Cannabis Inc. revealed its results earlier this week. You would have to watch very closely to find them, though: The company only released results into the Canadian securities regulator’s database late Thursday, just before a 45-day deadline elapsed. --- This episode is sponsored by · Anchor: The easiest way to make a podcast. https://anchor.fm/app Support this podcast: https://anchor.fm/carterfarrpodcast/support

Like any hot and relatively new sector, the cannabis industry can be confusing, with high potential for scams, as the Securities and Exchange Commission has warned, so investors need to know the basics. To start with, there are a handful of large companies that actually touch the marijuana plant — an important distinction — and there are metrics that are unique to the industry that can help investors understand the underlying business.There are six large public cannabis companies that demand attention: Aphria Inc.APHQF, -4.04% APH, -3.97% , Aurora Cannabis Inc. ACBFF, -3.94% ACB, -2.85% , Cronos Group Inc. CRON, -3.59% CRON, -3.42% , Canopy Growth Corp. CGC, -7.57% WEED, -6.96% , GW Pharmaceuticals PLC GWPH, +1.55% and Tilray Inc.TLRY, -5.23% TLRY, -5.23% . Five are Canadian and trade on the Toronto Stock Exchange and on U.S. exchanges or on the over-the-counter market, while one is U.K.-based.All produce thousands of kilograms of weed each quarter, which is critical, as there are dozens of smaller businesses both public and private that have yet to bring products to market. Some of those are expected to die, and some are expected to thrive.

Like any hot and relatively new sector, the cannabis industry can be confusing, with high potential for scams, as the Securities and Exchange Commission has warned, so investors need to know the basics. To start with, there are a handful of large companies that actually touch the marijuana plant — an important distinction — and there are metrics that are unique to the industry that can help investors understand the underlying business. There are six large public cannabis companies that demand attention: Aphria Inc.APHQF, -4.04% APH, -3.97% , Aurora Cannabis Inc. ACBFF, -3.94% ACB, -2.85% , Cronos Group Inc. CRON, -3.59% CRON, -3.42% , Canopy Growth Corp. CGC, -7.57% WEED, -6.96% , GW Pharmaceuticals PLC GWPH, +1.55% and Tilray Inc.TLRY, -5.23% TLRY, -5.23% . Five are Canadian and trade on the Toronto Stock Exchange and on U.S. exchanges or on the over-the-counter market, while one is U.K.-based. All produce thousands of kilograms of weed each quarter, which is critical, as there are dozens of smaller businesses both public and private that have yet to bring products to market. Some of those are expected to die, and some are expected to thrive.

Like any hot and relatively new sector, the cannabis industry can be confusing, with high potential for scams, as the Securities and Exchange Commission has warned, so investors need to know the basics. To start with, there are a handful of large companies that actually touch the marijuana plant — an important distinction — and there are metrics that are unique to the industry that can help investors understand the underlying business.There are six large public cannabis companies that demand attention: Aphria Inc.APHQF, -4.04% APH, -3.97% , Aurora Cannabis Inc. ACBFF, -3.94% ACB, -2.85% , Cronos Group Inc. CRON, -3.59% CRON, -3.42% , Canopy Growth Corp. CGC, -7.57% WEED, -6.96% , GW Pharmaceuticals PLC GWPH, +1.55% and Tilray Inc.TLRY, -5.23% TLRY, -5.23% . Five are Canadian and trade on the Toronto Stock Exchange and on U.S. exchanges or on the over-the-counter market, while one is U.K.-based.All produce thousands of kilograms of weed each quarter, which is critical, as there are dozens of smaller businesses both public and private that have yet to bring products to market. Some of those are expected to die, and some are expected to thrive.

Like any hot and relatively new sector, the cannabis industry can be confusing, with high potential for scams, as the Securities and Exchange Commission has warned, so investors need to know the basics. To start with, there are a handful of large companies that actually touch the marijuana plant — an important distinction — and there are metrics that are unique to the industry that can help investors understand the underlying business. There are six large public cannabis companies that demand attention: Aphria Inc.APHQF, -4.04% APH, -3.97% , Aurora Cannabis Inc. ACBFF, -3.94% ACB, -2.85% , Cronos Group Inc. CRON, -3.59% CRON, -3.42% , Canopy Growth Corp. CGC, -7.57% WEED, -6.96% , GW Pharmaceuticals PLC GWPH, +1.55% and Tilray Inc.TLRY, -5.23% TLRY, -5.23% . Five are Canadian and trade on the Toronto Stock Exchange and on U.S. exchanges or on the over-the-counter market, while one is U.K.-based. All produce thousands of kilograms of weed each quarter, which is critical, as there are dozens of smaller businesses both public and private that have yet to bring products to market. Some of those are expected to die, and some are expected to thrive.

A leader in the #Cannabis sector, now enjoying a healthy rest on contracting volume. $cgc

On October 17th, marijuana goes fully legal in Canada. This event, combined with the Canopy Growth Corp investment made by Constellation Brands / Stories of Coca-Cola entering CBD beverages have made the cannabis space the most discussed sector in the past few weeks. What events will unfold over the upcoming months that will either continue to validate the sector OR perhaps send these sky-rocketing valuations back down to earth? I sat down with Navy Capital's Sean Stiefel to discuss. Navy was formed in 2014 as a fund specifically designed to participate in the upside from cannabis.

A volatile stock, that is rocking a Stage 2 continuation breakout! $weed.ca $study

Del två av två i vår djupdykning i de ack så heta cannabisaktierna. Till vår hjälp har vi åter igen med oss "8eunderverket"! Podden produceras av IPO.se Följ oss på Twitter: twitter.com/marketmakerspod Följ oss på Facebook: www.facebook.com/marketmakerspod/ Följ Ola på Twitter: twitter.com/8eunderverket Läs Olas blogg: 8eunderverketsresa.blogspot.se/ Bolag som nämns i dagens avsnitt: - Amazon / JP Morgan / Berkshire Hathaway - Facebook / Alphabet / Microsoft / Apple - Hennes & Mauritz - Boeing / Cuberg - Volkswagen / Daimler / BMW - Deutsche Bank / UBS / HSBC - Cannabis Wheaton Income Corp. - Maricann Group Inc. - CannTrust Holdings Inc. - Canopy Growth Corp. - Aphria Inc. - Aurora Cannabis - GW Pharmaceuticals - Horizons Marijuana Life Sciences Index / Evolve Marijuana ETF See acast.com/privacy for privacy and opt-out information.

Lennar’s purchase of rival CalAtlantic Group creates the largest homebuilder in the U.S.  Taylor Muckerman and Jason Moser analyze the deal and the future for homebuilding stocks.  Macy’s hits an 8-year low. Ellie Mae reports earnings.  And Constellation Brands buys a 10% stake in Canopy Growth Corp., a publicly-traded cannabis company with an all-time great ticker symbol.

Are you offended by Cam Newton's comments? Can the US ever ban guns? Should Canada take more pride in legalizing cannabis? Comedians Bryan Callen and Perry Perlmutar who Co-Hosts, Founder of Canopy Growth Corp and co-founder of Tweed Inc Bruce Linton plus Rogers Hometown Hockey Co-Host Tara Slone.

This week on #PotStockRadio Eric Butz @PotStockEric Ryan Godfrey @ryanmgodfrey  Chris Trace @supergravy welcome a company we've been following for a long time. We'll have Chuck Rafici former CEO of Canopy Growth Corp to discuss the company who is currently producing MMJ in Canada. They have announced some exciting partnerships that will be discussed and should make for an exciting show!  As always any questions or feedback about the show can be directed to eric@potstockradio.com PotStockRadio does not condone or promote the use of any illegal substance. Also, PotStockRadio is for educational and informational purposes only!

Benzinga Cannabis Hour is a Weekly {online} show on Thursdays that will focus on the latest news and business trends in the cannabis industry. This week's Expert Guests: Pankaj Talwar: CEO, Copperstate Farms John Arbuthnot: Co-Founder, CEO, & Director,  Delta 9 Cannabis Inc. Sol Clahane: VP & General Manager of US Region, Canopy Growth Corp. Get Notified for Future BZ Cannabis Events If you want to be informed of our upcoming Benzinga Cannabis Events, please fill out the form below to receive updates. https://www.benzinga.com/events/cannabis/cannabis-hour/